表纸
市场调查报告书
商品编码
1019502

自体免疫疾病治疗药的全球市场(2021年~2025年)

Global Autoimmune Drugs Market 2021-2025

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 订单完成后即时交付

价格
  • 全貌
  • 简介
  • 目录
简介

自体免疫疾病治疗药的市场规模在2021年~2025年的预测期间内,预计将以6%的年复合成长率推移,并成长到238亿6,000万美元。

自体免疫疾病治疗药市场相关之本报告提供整体分析,市场规模与预测,趋势,涵括成长要素,课题,以及约25位供应商的供应商分析。

该市场成长的主要因素有出负担得起的生物仿制药和生物制药的靶向治疗机制。

本报告提供自体免疫疾病治疗药市场调查,市场概要,市场规模,市场预测,客户形势,各治疗领域·各地区的分析,再加上业者情势和供应商分析等。

目录

摘要整理

市场形势

  • 市场生态系统
  • 价值链分析

市场规模

  • 市场定义
  • 市场区隔分析
  • 市场规模:2020年
  • 市场预测:从2020年~2025年的预测

波特的五力分析

  • 买方议价能力
  • 供给企业谈判力
  • 新加入厂商业者的威胁
  • 替代品的威胁
  • 竞争的威胁
  • 市场情况

各治疗领域市场区隔

  • 市场区隔
  • 类风湿性关节炎:市场规模与预测(2020年~2025年)
  • 多发性硬化症:市场规模与预测(2020年~2025年)
  • 干癣:市场规模与预测(2020年~2025年)
  • 发炎性肠道疾病:市场规模与预测(2020年~2025年)
  • 其他:市场规模与预测(2020年~2025年)

客户形势

  • 概要

各地区形势

  • 各地区市场区隔
  • 各地区比较
  • 北美:市场规模与预测(2020年~2025年)
  • 欧洲:市场规模与预测(2020年~2025年)
  • 亚洲:市场规模与预测(2020年~2025年)
  • 其他地区:市场规模与预测(2020年~2025年)
  • 主要国家
  • 各地区形势市场机会
  • 市场成长促进因素
  • 市场课题
  • 市场趋势

业者情势

  • 概要
  • 创造性破坏状况

供应商分析

  • 交易厂商
  • 供应商的市场定位
  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

附录

目录
Product Code: IRTNTR70662

Technavio has been monitoring the autoimmune drugs market and it is poised to grow by $ 23.86 bn during 2021-2025, progressing at a CAGR of almost 6% during the forecast period. Our report on autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the introduction of affordable biosimilars and targeted therapeutic mechanism of biologics. In addition, introduction of affordable biosimilars is anticipated to boost the growth of the market as well.

The autoimmune drugs market analysis includes therapy area segment and geographic landscape.

Technavio's autoimmune drugs market is segmented as below:

By Therapy Area

  • Rheumatoid arthritis
  • Multiple sclerosis
  • Psoriasis
  • Inflammatory bowel disease
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the strong R&D pipeline as one of the prime reasons driving the autoimmune drugs market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on autoimmune drugs market covers the following areas:

  • Autoimmune drugs market sizing
  • Autoimmune drugs market forecast
  • Autoimmune drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune drugs market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the autoimmune drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Therapy area
    • Market segments
    • Rheumatoid arthritis - Market size and forecast 2020-2025
    • Multiple sclerosis - Market size and forecast 2020-2025
    • Psoriasis - Market size and forecast 2020-2025
    • Inflammatory bowel disease - Market size and forecast 2020-2025
    • Others - Market size and forecast 2020-2025
  • Customer landscape
    • Overview
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • AbbVie Inc.
    • Amgen Inc.
    • Bristol-Myers Squibb Co.
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline Plc
    • Johnson and Johnson Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Other1 - Market share 2020-2025 (%)
  • 22: Comparison by Other1
  • 23: Rheumatoid arthritis - Market size and forecast 2020-2025 ($ million)
  • 24: Rheumatoid arthritis - Year-over-year growth 2020-2025 (%)
  • 25: Multiple sclerosis - Market size and forecast 2020-2025 ($ million)
  • 26: Multiple sclerosis - Year-over-year growth 2020-2025 (%)
  • 27: Psoriasis - Market size and forecast 2020-2025 ($ million)
  • 28: Psoriasis - Year-over-year growth 2020-2025 (%)
  • 29: Inflammatory bowel disease - Market size and forecast 2020-2025 ($ million)
  • 30: Inflammatory bowel disease - Year-over-year growth 2020-2025 (%)
  • 31: Others - Market size and forecast 2020-2025 ($ million)
  • 32: Others - Year-over-year growth 2020-2025 (%)
  • 33: Market opportunity by Other1
  • 34: Customer landscape
  • 35: Market share By Geographical Landscape 2020-2025 (%)
  • 36: Geographic comparison
  • 37: North America - Market size and forecast 2020-2025 ($ million)
  • 38: North America - Year-over-year growth 2020-2025 (%)
  • 39: Europe - Market size and forecast 2020-2025 ($ million)
  • 40: Europe - Year-over-year growth 2020-2025 (%)
  • 41: Asia - Market size and forecast 2020-2025 ($ million)
  • 42: Asia - Year-over-year growth 2020-2025 (%)
  • 43: ROW - Market size and forecast 2020-2025 ($ million)
  • 44: ROW - Year-over-year growth 2020-2025 (%)
  • 45: Key leading countries
  • 46: Market opportunity By Geographical Landscape ($ million)
  • 47: Impact of drivers and challenges
  • 48: Vendor landscape
  • 49: Landscape disruption
  • 50: Industry risks
  • 51: Vendors covered
  • 52: Market positioning of vendors
  • 53: Abbott Laboratories - Overview
  • 54: Abbott Laboratories - Business segments
  • 55: Abbott Laboratories - Key offerings
  • 56: Abbott Laboratories - Key customers
  • 57: Abbott Laboratories - Segment focus
  • 58: AbbVie Inc. - Overview
  • 59: AbbVie Inc. - Product and service
  • 60: AbbVie Inc. - Key offerings
  • 61: AbbVie Inc. - Key customers
  • 62: AbbVie Inc. - Segment focus
  • 63: Amgen Inc. - Overview
  • 64: Amgen Inc. - Business segments
  • 65: Amgen Inc. - Key offerings
  • 66: Amgen Inc. - Key customers
  • 67: Amgen Inc. - Segment focus
  • 68: Bristol-Myers Squibb Co. - Overview
  • 69: Bristol-Myers Squibb Co. - Product and service
  • 70: Bristol-Myers Squibb Co. - Key offerings
  • 71: Bristol-Myers Squibb Co. - Key customers
  • 72: Bristol-Myers Squibb Co. - Segment focus
  • 73: F. Hoffmann-La Roche Ltd. - Overview
  • 74: F. Hoffmann-La Roche Ltd. - Business segments
  • 75: F. Hoffmann-La Roche Ltd. - Key offerings
  • 76: F. Hoffmann-La Roche Ltd. - Key customers
  • 77: F. Hoffmann-La Roche Ltd. - Segment focus
  • 78: GlaxoSmithKline Plc - Overview
  • 79: GlaxoSmithKline Plc - Business segments
  • 80: GlaxoSmithKline Plc - Key offerings
  • 81: GlaxoSmithKline Plc - Key customers
  • 82: GlaxoSmithKline Plc - Segment focus
  • 83: Johnson and Johnson Inc. - Overview
  • 84: Johnson and Johnson Inc. - Business segments
  • 85: Johnson and Johnson Inc. - Key offerings
  • 86: Johnson and Johnson Inc. - Key customers
  • 87: Johnson and Johnson Inc. - Segment focus
  • 88: Novartis AG - Overview
  • 89: Novartis AG - Business segments
  • 90: Novartis AG - Key offerings
  • 91: Novartis AG - Key customers
  • 92: Novartis AG - Segment focus
  • 93: Pfizer Inc. - Overview
  • 94: Pfizer Inc. - Business segments
  • 95: Pfizer Inc. - Key offerings
  • 96: Pfizer Inc. - Key customers
  • 97: Pfizer Inc. - Segment focus
  • 98: Sanofi SA - Overview
  • 99: Sanofi SA - Business segments
  • 100: Sanofi SA - Key offerings
  • 101: Sanofi SA - Key customers
  • 102: Sanofi SA - Segment focus
  • 103: Currency conversion rates for US$
  • 104: Research Methodology
  • 105: Validation techniques employed for market sizing
  • 106: Information sources
  • 107: List of abbreviations